Skip to main content

Table 3 Age as per FDA-approved product label for drugs under study with such specification

From: Off-label use of cancer therapies in women diagnosed with breast cancer in the United States

Drug name Labeled age (years) 1
Clofarabine 1-21
Fluoxymesterone ≤50
Goserelin ≤50
Anastrozole ≥50
Exemestane ≥50
Fulvestrant ≥50
Letrozole ≥50
Gemtuzumab ozogamicin ≥50
  1. 1For the purpose of this study, age of menopause was fixed at 50 years.